AzTrials
AzTrials

Muscle DamageEMBERNCT04841772

Exploring Muscle Breakdown During Exercise Recovery

A study testing Recover Vegan Protein Supplement in people with Muscle Damage and Healthy, run by University of Exeter at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will allow researchers to explore how muscle responds to heavy exercise. The researchers will characterise rates of muscle protein breakdown and synthesis 24hours after heavy exercise with a post exercise protein polyphenol or placebo supplementation. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Muscle Damage, Healthy
What is being tested?
Recover Vegan Protein Supplement
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
26 participants
Where
1 siteUnited Kingdom
Study dates
8 Apr 2021to 1 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Recreationally active
  • 18-40 years of age

Who cannot join

  • Regular and structured involvement in resistance training
  • Inactive participants
  • Habitual dietary protein intake <0.8g/kg bw/day and >2.0g/kg bw/day
  • Regular use of nutritional supplements known to suppress inflammation or modulate protein metabolism Any diagnosed metabolic conditions (diabetes), cardiovascular disease or hypertension
  • Current musculoskeletal injury
  • Chronic use of anti-inflammatory medicines
Show all 20Show fewer
  • Any known disorders in muscle metabolism
  • Individuals with an allergy to egg, fish, wheat or soy ingredients as the product is manufactured in a facility that contains these ingredients
  • Allergy to lidocaine
  • Having received or ingested a stable isotope tracer containing 15N in the past
  • A personal or family history of epilepsy, seizures or schizophrenia
  • Stomach bleeding or stomach ulcer
  • Kidney failure
  • Liver problems, such as fibrosis, cirrhosis or failure
  • Crohns disease or ulcerative colitis
  • Chickenpox or shingles
  • Pregnant or trying to get pregnant
  • Any diagnosed cardiovascular disease (e.g. deep vein thrombosis) or hypertension.
  • Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes)
  • Recent (within the last 6 months) or current musculoskeletal injury (leg fracture)

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University of Exeter

    Exeter, Devon, EX1 2LU

Other trials in United Kingdom

About this study

This study will allow researchers to explore how muscle responds to heavy exercise. The researchers will characterise rates of muscle protein breakdown and synthesis 24hours after heavy exercise with a post exercise protein polyphenol or placebo supplementation. This will inform strategies to help people recover from heavy exercise.

Read the detailed description

It is well known that resistance exercise increases rates of muscle protein synthesis and breakdown, with the rise in synthesis greater in magnitude and duration. The time course of rates of muscle protein synthesis increase dramatically 24-72h following eccentric exercise, even in a non-exercised control leg. This data is consistent with a much larger increase in muscle protein breakdown than previously thought. However, the response of muscle protein breakdown following damaging eccentric exercise, and its relationship with muscle protein synthesis, has not yet been elucidated. Moreover, it is unclear whether a protein and polyphenol nutritional intervention influence rates of muscle protein breakdown to accelerate recovery. This study will allow researchers to test the hypothesis that eccentric exercise increases rates of muscle protein breakdown independently of muscle contraction per se. If this hypothesis is supported, it will highlight that recovery strategies from muscle damage should also target supporting muscle protein breakdown.

Being tested
Recover Vegan Protein Supplement, Placebo
Keywords
Skeletal muscle, Postabsorptive, Muscle protein breakdown, Muscle protein synthesis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Recover Vegan Protein SupplementDietary supplement

    Post exercise protein supplement (26g pea protein)

  • PlaceboDietary supplement

    Post exercise placebo supplement (32g maltodextrin)

Study groups in NCT04841772
Study groupRoleWhat they receive
Vegan ProteinActive comparatorNot described
Receives: Dietary Supplement: Recover Vegan Protein Supplement
PlaceboPlacebo comparatorNot described
Receives: Dietary Supplement: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle protein breakdown rate

    Muscle protein breakdown rate (FBR, measured in %/h) 24hours post eccentric exercise.

    Measured: 1hour

Secondary outcomes (1)
  1. Muscle protein synthesis rate

    Muscle protein synthesis rate (FSR, measured in %/h) 24hours post eccentric exercise.

    Measured: 3hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Apr 2021
  2. Study start8 Apr 2021
  3. Primary completion1 Dec 2022
  4. Study completion1 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04841772
Sponsor's protocol ID
210203-B-01
Acronym
EMBER
Status last verified
Mar 2023
First submitted
9 Apr 2021
Last updated
23 Mar 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Recover Vegan Protein Supplement in people with Muscle Damage and Healthy, run by University of Exeter at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 20 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle protein breakdown rate (time frame: 1hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in